Q-Line Biotech
29 May '26SME
Min. Investment
₹2,60,800
Issue size
₹214.48 Cr
GMP
Locked
Overall subscription: 88.28x
Check allotment status
Expert verdict
IPO dates
21 May
Opening
25 May
Closing
26 May
Allotment
29 May
Listing
*Refunds will be initiated on 27 May '26
IPO quota
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 800 | ₹2,74,400 |
Subscription (as on 26 May 2026, 01:30 PM)
Overall88.28x
Qualified institutional buyers
Non-Institutional Buyers
Retail Investors
Employee
About company
Founded: 2010|MD: Mr Saurabh Garg
- Q-Line Biotech Limited is engaged in the development, manufacturing, and marketing of diagnostic reagents, consumables, and in-vitro diagnostic (IVD) equipment for healthcare and diagnostic applications.
- The company supplies products such as clinical chemistry reagents, haematology and immunodiagnostic products, molecular diagnostic kits, rapid test kits, point-of-care devices, analysers, laboratory consumables, and diagnostic instruments to diagnostic laboratories, hospitals, and medical colleges.
- It also provides annual maintenance and after-sales services for medical equipment. During the Covid-19 pandemic, the company developed products including RT-PCR kits, RNA extraction kits, and VTM kits.
- Q-Line Biotech operates multiple manufacturing facilities, warehouses, and offices in Lucknow, Uttar Pradesh, Delhi, Kolkata and Bhubaneswar. Its manufacturing operations include indigenous production of reagents and diagnostic analysers, while some products are manufactured under technical collaborations with international companies.
Issue Details & Objective
Lot size
400 Shares
Price band
₹326 to 343
Face value
₹10 per share
Financials
IPO reservation
Anchor investor - 28.48%
QIB - 19.00%
HNI - 14.26%
Retail - 33.25%
Download DRHP (IPO Doc)FAQs
Should I apply for the Q-Line Biotech IPO?
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
What is the issue size of Q-Line Biotech IPO?
The issue size of Q-Line Biotech IPO is ₹214.48 Cr
What are the open and close dates for Q-Line Biotech IPO?
The Q-Line Biotech IPO will be open for applications from 21 May '26 to 25 May '26
What is the lot size and minimum order quantity of Q-Line Biotech IPO?
The lot size of Q-Line Biotech IPO is 400 Shares and its minimum investment amount is ₹2,60,800.
What is the GMP value of Q-Line Biotech IPO?
Grey market premium (GMP) is a premium amount at which grey market IPO shares are traded before they get listed in the stock exchange. The GMP for Q-Line Biotech IPO is 29.45
Expert IPO analysisRESEARCH BACKED